These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease. DeMarshall CA; Han M; Nagele EP; Sarkar A; Acharya NK; Godsey G; Goldwaser EL; Kosciuk M; Thayasivam U; Belinka B; Nagele RG; Immunol Lett; 2015 Nov; 168(1):80-8. PubMed ID: 26386375 [TBL] [Abstract][Full Text] [Related]
28. Premotor Parkinson's disease: Overview of clinical symptoms and current diagnostic methods. Kaiserova M; Grambalova Z; Kurcova S; Otruba P; Prikrylova Vranova H; Mensikova K; Kanovsky P Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Jun; 165(2):103-112. PubMed ID: 33542542 [TBL] [Abstract][Full Text] [Related]
29. High-Accuracy Detection of Early Parkinson's Disease through Multimodal Features and Machine Learning. Prashanth R; Dutta Roy S; Mandal PK; Ghosh S Int J Med Inform; 2016 Jun; 90():13-21. PubMed ID: 27103193 [TBL] [Abstract][Full Text] [Related]
31. Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment. Bang Y; Lim J; Choi HJ Arch Pharm Res; 2021 Jun; 44(6):588-604. PubMed ID: 34145553 [TBL] [Abstract][Full Text] [Related]
32. Advances in Biomarker Research in Parkinson's Disease. Mehta SH; Adler CH Curr Neurol Neurosci Rep; 2016 Jan; 16(1):7. PubMed ID: 26711276 [TBL] [Abstract][Full Text] [Related]
33. When does Parkinson's disease begin? Gaig C; Tolosa E Mov Disord; 2009; 24 Suppl 2():S656-64. PubMed ID: 19877243 [TBL] [Abstract][Full Text] [Related]
34. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression. Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P; BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448 [TBL] [Abstract][Full Text] [Related]
35. Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson's Disease. Xie F; Gao X; Yang W; Chang Z; Yang X; Wei X; Huang Z; Xie H; Yue Z; Zhou F; Wang Q ACS Chem Neurosci; 2019 Feb; 10(2):973-990. PubMed ID: 30590011 [TBL] [Abstract][Full Text] [Related]
36. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. During MJ; Kaplitt MG; Stern MB; Eidelberg D Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study. Liepelt-Scarfone I; Gauss K; Maetzler W; Müller K; Bormann C; Fruhmann Berger M; Timmers M; Streffer J; Berg D Neuroepidemiology; 2013; 41(3-4):174-82. PubMed ID: 24051361 [TBL] [Abstract][Full Text] [Related]
38. MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine. Mingazov ER; Khakimova GR; Kozina EA; Medvedev AE; Buneeva OA; Bazyan AS; Ugrumov MV Mol Neurobiol; 2018 Apr; 55(4):2991-3006. PubMed ID: 28456940 [TBL] [Abstract][Full Text] [Related]
40. A review on the new age methodologies for early detection of Alzheimer's and Parkinson's disease. Ghosh N; Sinha K; Sil PC Basic Clin Pharmacol Toxicol; 2024 May; 134(5):602-613. PubMed ID: 38482977 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]